Drug Profile
6-Homoneplanocin A
Alternative Names: HNPALatest Information Update: 23 Apr 2003
Price :
$50
*
At a glance
- Originator Asahi Kasei
- Class Antivirals; Purine nucleosides
- Mechanism of Action Adenosylhomocysteinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 15 Jan 2001 Asahi Chemical is now called Asahi Kasei
- 09 Sep 1997 New profile
- 09 Sep 1997 Preclinical development for Viral infections in Japan (Unknown route)